CAI
$18.54
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Intraday
Recent News
Caris Life Sciences (CAI) Valuation Check After Recent Share Price Rebound
Caris Life Sciences: Event Driven Snapshot Caris Life Sciences (CAI) has drawn investor attention after recent trading, with the stock closing at $19.05 and showing mixed performance over the past week, month and past 3 months. See our latest analysis for Caris Life Sciences. The recent 1 day share price return of 4.96% comes after a weaker stretch, with the 30 day and year to date share price returns of 7.61% and 29.39% declines indicating momentum has been fading rather than building. If...
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks rose late Monday afternoon, with the NYSE Health Care Index up 0.8% and the State
BTSG vs. CAI: Which Stock Is the Better Value Option?
BTSG vs. CAI: Which Stock Is the Better Value Option?
Assessing Caris Life Sciences (CAI) Valuation After Recent Share Price Weakness
Caris Life Sciences (CAI) has drawn fresh attention after recent trading left the stock with a one-month return of about a 13% decline and a three-month return near a 23% decline. See our latest analysis for Caris Life Sciences. Those recent share price returns, including a 4.68% 1 day gain and 3.12% 7 day gain against deeper 30 day and year to date share price declines, suggest short term momentum is improving after a weaker stretch. If you are watching how AI driven health companies are...
Caris Life Sciences Inc (CAI) Q4 2025 Earnings Call Highlights: Record Revenue Surge and ...
Caris Life Sciences Inc (CAI) reports a 125% revenue increase, positive net income, and ambitious 2026 growth targets, driven by molecular profiling success and upcoming innovations.